IRF1 and neoplasm: Thus, we found that PARP14 pharmacological antagonism or silencing in tumour cells enhanced STAT1 phosphorylation and expression of STAT1 target gene products, including IRF1 responsible for the expression of many IFNγ signalling genes but also PARP14 itself53,54.